4688美高梅

  • 中国4688美高梅集团(股份)有限公司-官方网站
  • 中国4688美高梅集团(股份)有限公司-官方网站

    About Doer

    Zhejiang Doer Biologics Co., Ltd. was established on April 1, 2014, with a registered capital of 52.12 million yuan. The company is a high-tech enterprise specializing in innovative biopharmaceutical development under Huadong Medicine (stock code: SZ.000963). Its R&D center is located in the Hangzhou Medicine Port Town.

    中国4688美高梅集团(股份)有限公司-官方网站
    Group Photo of Dr. Junfang Xu, Dr. Yongliang Fang, and Prof. Jianping Li's Team at the AHA 2025 Conference
    中国4688美高梅集团(股份)有限公司-官方网站
    Dr. Yongliang Fang Attends EASL 2025
    中国4688美高梅集团(股份)有限公司-官方网站
    DR510 Debuts at the ESMO 2025 Congress
    中国4688美高梅集团(股份)有限公司-官方网站
    Dr. Yongliang Fang and Dr. Junfang Xu Attend AACR2026

    Technology

    Technology platform

    xLONGylation?--recombinant PEG-like polypeptide platform

    xLONGylation?--recombinant PEG-like polypeptide platform
    Read more

    MultipleBody?--Multi-targeted biotherapeutics

    MultipleBody?--Multi-targeted biotherapeutics
    Read more

    AccuBody?--Accurately activated antibody for precision tumor therapy

    AccuBody?--Accurately activated antibody for precision tumor therapy
    Read more

    News

    News Center
    【网站地图】